These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
199 related articles for article (PubMed ID: 32216312)
1. Rapid Prostate Cancer Noninvasive Biomarker Screening Using Segmented Flow Mass Spectrometry-Based Untargeted Metabolomics. Pinto FG; Mahmud I; Harmon TA; Rubio VY; Garrett TJ J Proteome Res; 2020 May; 19(5):2080-2091. PubMed ID: 32216312 [TBL] [Abstract][Full Text] [Related]
2. Evaluation of the technical variations and the suitability of a hydrophilic interaction liquid chromatography-high resolution mass spectrometry (ZIC-pHILIC-Exactive orbitrap) for clinical urinary metabolomics study. Zhang T; Watson DG J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Jun; 1022():199-205. PubMed ID: 27107246 [TBL] [Abstract][Full Text] [Related]
3. Untargeted metabolomics of prostate cancer zwitterionic and positively charged compounds in urine. Cerrato A; Bedia C; Capriotti AL; Cavaliere C; Gentile V; Maggi M; Montone CM; Piovesana S; Sciarra A; Tauler R; Laganà A Anal Chim Acta; 2021 May; 1158():338381. PubMed ID: 33863412 [TBL] [Abstract][Full Text] [Related]
4. Application of Holistic Liquid Chromatography-High Resolution Mass Spectrometry Based Urinary Metabolomics for Prostate Cancer Detection and Biomarker Discovery. Zhang T; Watson DG; Wang L; Abbas M; Murdoch L; Bashford L; Ahmad I; Lam NY; Ng AC; Leung HY PLoS One; 2013; 8(6):e65880. PubMed ID: 23823321 [TBL] [Abstract][Full Text] [Related]
5. Identification of prediagnostic metabolites associated with prostate cancer risk by untargeted mass spectrometry-based metabolomics: A case-control study nested in the Northern Sweden Health and Disease Study. Östman JR; Pinto RC; Ebbels TMD; Thysell E; Hallmans G; Moazzami AA Int J Cancer; 2022 Dec; 151(12):2115-2127. PubMed ID: 35866293 [TBL] [Abstract][Full Text] [Related]
6. Identifying Hair Biomarker Candidates for Alzheimer's Disease Using Three High Resolution Mass Spectrometry-Based Untargeted Metabolomics Strategies. Chang CW; Hsu JY; Hsiao PZ; Chen YC; Liao PC J Am Soc Mass Spectrom; 2023 Apr; 34(4):550-561. PubMed ID: 36973238 [TBL] [Abstract][Full Text] [Related]
7. Mass spectrometric based approaches in urine metabolomics and biomarker discovery. Khamis MM; Adamko DJ; El-Aneed A Mass Spectrom Rev; 2017 Mar; 36(2):115-134. PubMed ID: 25881008 [TBL] [Abstract][Full Text] [Related]
8. Development of simultaneous targeted metabolite quantification and untargeted metabolomics strategy using dual-column liquid chromatography coupled with tandem mass spectrometry. Gao Y; Chen Y; Yue X; He J; Zhang R; Xu J; Zhou Z; Wang Z; Zhang R; Abliz Z Anal Chim Acta; 2018 Dec; 1037():369-379. PubMed ID: 30292313 [TBL] [Abstract][Full Text] [Related]
9. A one-year pilot study comparing direct-infusion high resolution mass spectrometry based untargeted metabolomics to targeted diagnostic screening for inherited metabolic diseases. Willems AP; van der Ham M; Schiebergen-Bronkhorst BGM; van Aalderen M; de Barse MMJ; De Gruyter FE; van Hoek IN; Pras-Raves ML; de Sain-van der Velden MGM; Prinsen HCMT; Verhoeven-Duif NM; Jans JJM Front Mol Biosci; 2023; 10():1283083. PubMed ID: 38028537 [No Abstract] [Full Text] [Related]
10. GC-MS-based metabolomics reveals new biomarkers to assist the differentiation of prostate cancer and benign prostatic hyperplasia. Wang W; He Z; Kong Y; Liu Z; Gong L Clin Chim Acta; 2021 Aug; 519():10-17. PubMed ID: 33831421 [TBL] [Abstract][Full Text] [Related]
11. Model-driven data curation pipeline for LC-MS-based untargeted metabolomics. Riquelme G; Bortolotto EE; Dombald M; Monge ME Metabolomics; 2023 Mar; 19(3):15. PubMed ID: 36856823 [TBL] [Abstract][Full Text] [Related]
12. Data-Driven Soft Independent Modeling of Class Analogy in Paper Spray Ionization Mass Spectrometry-Based Metabolomics for Rapid Detection of Prostate Cancer. Pinto FG; Mahmud I; Rubio VY; Máquina ADV; Furtado Durans AF; Neto WB; Garrett TJ Anal Chem; 2022 Feb; 94(4):1925-1931. PubMed ID: 35060703 [TBL] [Abstract][Full Text] [Related]
13. Combined hydrophilic interaction liquid chromatography-scanning field asymmetric waveform ion mobility spectrometry-time-of-flight mass spectrometry for untargeted metabolomics. Szykuła KM; Meurs J; Turner MA; Creaser CS; Reynolds JC Anal Bioanal Chem; 2019 Sep; 411(24):6309-6317. PubMed ID: 31011786 [TBL] [Abstract][Full Text] [Related]
14. Urinary exposure marker discovery for toxicants using ultra-high pressure liquid chromatography coupled with Orbitrap high resolution mass spectrometry and three untargeted metabolomics approaches. Hsu JY; Hsu JF; Chen YR; Shih CL; Hsu YS; Chen YJ; Tsai SH; Liao PC Anal Chim Acta; 2016 Oct; 939():73-83. PubMed ID: 27639145 [TBL] [Abstract][Full Text] [Related]
15. Identification of novel biomarkers in the early diagnosis of malignant melanoma by untargeted liquid chromatography coupled to high-resolution mass spectrometry-based metabolomics: a pilot study. Peña-Martín J; Belén García-Ortega M; Palacios-Ferrer JL; Díaz C; Ángel García M; Boulaiz H; Valdivia J; Jurado JM; Almazan-Fernandez FM; Arias Santiago S; Vicente F; Del Val C; Pérez Del Palacio J; Marchal JA Br J Dermatol; 2024 Apr; 190(5):740-750. PubMed ID: 38214572 [TBL] [Abstract][Full Text] [Related]
16. SANIST: a rapid mass spectrometric SACI/ESI data acquisition and elaboration platform for verifying potential candidate biomarkers. Albini A; Briga D; Conti M; Bruno A; Farioli D; Canali S; Sogno I; D'Ambrosio G; Consonni P; Noonan DM Rapid Commun Mass Spectrom; 2015 Oct; 29(19):1703-10. PubMed ID: 26331920 [TBL] [Abstract][Full Text] [Related]
17. A Metabolomic Approach Applied to a Liquid Chromatography Coupled to High-Resolution Tandem Mass Spectrometry Method (HPLC-ESI-HRMS/MS): Towards the Comprehensive Evaluation of the Chemical Composition of Cannabis Medicinal Extracts. Citti C; Battisti UM; Braghiroli D; Ciccarella G; Schmid M; Vandelli MA; Cannazza G Phytochem Anal; 2018 Mar; 29(2):144-155. PubMed ID: 28915313 [TBL] [Abstract][Full Text] [Related]
19. Enhancing coverage in LC-MS-based untargeted metabolomics by a new sample preparation procedure using mixed-mode solid-phase extraction and two derivatizations. Wu Q; Xu Y; Ji H; Wang Y; Zhang Z; Lu H Anal Bioanal Chem; 2019 Sep; 411(23):6189-6202. PubMed ID: 31414155 [TBL] [Abstract][Full Text] [Related]
20. Untargeted Metabolomic Profile for the Detection of Prostate Carcinoma-Preliminary Results from PARAFAC2 and PLS-DA Models. Amante E; Salomone A; Alladio E; Vincenti M; Porpiglia F; Bro R Molecules; 2019 Aug; 24(17):. PubMed ID: 31443574 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]